论文部分内容阅读
英国胸腔协会(BTA)采用异烟肼(H)、利福平(R)6个月,前2个月分别加用乙胺丁醇(E)、匹嗪酰胺(Z)或链霉素(S)、匹嗪酰胺的两个化疗方案(EHRZ6)(SHRZ6),并与前推荐的H+R,前2个月仅加用E的9个月方案(EHR9)疗效作对照观察。511例病人随机分为3组,分别为(EHRZ6)164例、(SHRZ6)170例、(EHR9)177例。年龄18～60岁。全部痰结核杆菌培养阳性,58%直接涂片阳性。结核病变1/3病人轻度、1/3限局、另1/3中重度;半数有空洞。均未经2周以上的抗结核治疗,但23例菌
BTA used isoniazid (H) and rifampicin (R) for 6 months. Ethambutol (E), Piazinamide (Z) or streptomycin (EHRZ6) (SHRZ6), and were compared with the pre-recommended H + R, 9 months regimen plus E only for the first 2 months (EHR9). 511 patients were randomly divided into 3 groups: 164 cases (EHRZ6), 170 cases (SHRZ6) and 177 cases (EHR9). Age 18 ~ 60 years old. All sputum positive Mycobacterium tuberculosis culture, 58% direct smear-positive. Tuberculosis 1/3 patients mild, 1/3 limit Council, and the other 1/3 moderate; half empty. None of the patients had anti-TB therapy more than 2 weeks, but 23 cases of bacteria